TheEdgeResearch
Home / Stocks / NUVO

Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)

NASDAQ Healthcare Medical - Devices
$0.17 ▲ +100.00%
Market Cap
$5.7M
Sector
Healthcare
Industry
Medical - Devices
Beta
-0.41
52-Wk Range
0.17-0.22
CEO
Robert Maurice Powell Jr.
Country
IL
Currency
USD

Holdco Nuvo Group D.G Ltd. Ordinary Shares operates in the Medical - Devices industry of the Healthcare sector, headquartered in Tel Aviv, IL. The stock last traded at $0.17, up 100.00% on the session, giving a market capitalisation of $5.7M. On trailing twelve-month figures it carries a trailing P/E of -0.10, a net margin of -19122.2%. Its beta of -0.41 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.10
Price / Sales
32.13
Price / Book
-0.05
EV / EBITDA
-0.50
Gross margin
-8.5%
Operating margin
-9450.6%
Net margin
-19122.2%
Return on equity
Debt / equity
-0.17
Current ratio
0.05
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
IPO date
2023-06-30
Headquarters
Tel Aviv, IL
About Holdco Nuvo Group D.G Ltd. Ordinary Shares

Holdco Nuvo Group D.G Ltd specializes in the innovation, development, and commercialization of medical devices designed for monitoring pregnancies. Its operations span Israel, the United States, and international markets. The company's key offering is the INVU platform, a remote pregnancy monitoring system that provides expectant mothers with a wearable, self-applied wireless sensor. This technology empowers both the mothers and their obstetricians to track maternal and fetal heart rates, along with maternal uterine activity, conveniently from the comfort of home or within a clinical setting, starting from the 32nd week of gestation until the commencement of labor. The INVU platform itself comprises two main elements: a sophisticated wireless sensor band that utilizes multi-modality technology to capture essential physiological signals, and a complementary cloud-based computing environment. This cloud system is responsible for processing and analyzing the collected data, subsequently generating and delivering customized reports on maternal and fetal health metrics. These insights are then conveyed to the mother and her obstetrician through intuitive digital visualization tools. The company has established strategic partnerships with Royal Philips and Charité – Universitätsmedizin Berlin. Founded in 2006, the firm maintains its headquarters in Tel Aviv, Israel, and was formerly known as Nuvo Group Ltd. before changing its name to Holdco Nuvo Group D.G Ltd in May 2024. Notably, on August 22, 2024, Holdco Nuvo Group D.G Ltd initiated Chapter 11 reorganization proceedings by filing a voluntary petition with the U.S. Bankruptcy Court for the District of Delaware.

Comparable companies

Holdco Nuvo Group D.G Ltd. Ordinary Shares is most often compared with the following Healthcare names:

ENTOGBNHMDGSMODVNVTAOBLNRHEPTCDAUPHVRAY
More research on NUVO
NUVO technical analysis NUVO TheEdge Score Compare against peers
Open full interactive analysis & DCF →